One-Vector System for Multiplexed CRISPR/Cas9 Against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors
Molecular Therapy - Nucleic Acids - United States
doi 10.1016/j.omtn.2018.05.006
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2018
Authors
Publisher
Elsevier BV